Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AtriCure projects 2026 adjusted EBITDA of $91M-$94M as it targets BoxX-NoAF enrollment completion by year-end (NASDAQ:ATRC)

Summary by Seeking Alpha
AtriCure Q3 2026 earnings: revenue rose 15%, EBITDA outlook increased, and BoxX-NoAF nears enrollment amid market headwinds.

2 Articles

The Motley FoolThe Motley Fool
Lean Left

AtriCure (ATRC) Q3 2026 Earnings Call Transcript

Net income turned positive as profitability outlook was raised for the year.

·Alexandria, United States
Read Full Article
Seeking AlphaSeeking Alpha
Lean Right

AtriCure projects 2026 adjusted EBITDA of $91M-$94M as it targets BoxX-NoAF enrollment completion by year-end (NASDAQ:ATRC)

AtriCure Q3 2026 earnings: revenue rose 15%, EBITDA outlook increased, and BoxX-NoAF nears enrollment amid market headwinds.

·Ra'anana, Israel
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Wednesday, November 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Mason, Ohio icon

Mason, Ohio

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal